Clinical Trials on Kidney Clear Cell Carcinoma
Total 12498 results
-
PfizerCompletedMetastatic Renal Cell Carcinoma (mRCC)Spain, Italy, Belgium, France, United Kingdom, Austria, Greece, Netherlands
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingAdvanced or Metastatic Renal Cell CarcinomaJapan
-
PfizerCompletedMetastatic Renal Cell Carcinoma ( mRCC)Ecuador, Argentina, Brazil, Colombia
-
Ceevra, Inc.CompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedCollecting Duct Carcinoma (Kidney)Italy
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Unknown
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
University Hospital, BordeauxNational Cancer Institute (NCI)Completed
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's Hospital; Vanderbilt...CompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterEli Lilly and CompanyCompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedKidney Cancer | Renal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)Not yet recruitingRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Undifferentiated Carcinoma | Recurrent Ovarian Clear Cell Adenocarcinoma | Recurrent Ovarian Undifferentiated Carcinoma and other conditions
-
Trans Tasman Radiation Oncology GroupActive, not recruitingRenal Cell CarcinomaAustralia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnRenal Cell Carcinoma | Stage I Renal Cell Cancer AJCC v8 | Stage II Renal Cell Cancer AJCC v8United States
-
Mayo ClinicRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Fallopian Tube Carcinosarcoma | Primary Peritoneal Carcinosarcoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian... and other conditionsUnited States
-
Bristol-Myers SquibbActive, not recruitingKidney Cancer | Renal Cell Carcinoma | Renal Cell Cancer | Adenocarcinoma Of Kidney | Adenocarcinoma, Renal Cell | Cancer of the KidneyFrance
-
PfizerCompletedCarcinoma | Renal CellUnited Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingOvarian Endometrioid Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Ovarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Primary Peritoneal Clear... and other conditionsUnited States
-
Cathay General HospitalCompletedOvarian Cancer | Adverse EffectsTaiwan
-
All India Institute of Medical Sciences, New DelhiCompletedRenal Cell Carcinoma | Transitional Cell Carcinoma | AML | Renal CystsIndia
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage IV Renal Cell CancerUnited States
-
Ludwig Institute for Cancer ResearchRadboud University Medical CenterCompletedMetastatic Renal Cell CarcinomaNetherlands
-
IpsenCompletedAdvanced Renal Cell Carcinoma (aRCC)United Kingdom
-
PfizerCompletedComplete Remission in Renal Cell CarcinomaFrance
-
Novartis PharmaceuticalsCompletedCancer | Renal Cell Carcinoma (RCC)United States, Belgium, Canada, Spain, United Kingdom, Turkey, Austria, Argentina, Brazil, Czechia, France, Germany, Israel, Italy, Poland, Russian Federation, Korea, Republic of, Chile, China, Greece, Hungary, Ireland, Slovakia, Japan, Denmar... and more
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma (mRCC)Germany
-
Immutep S.A.S.UmanisCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Fallopian Tube Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube... and other conditionsUnited States
-
PfizerCompletedMetastatic/Advanced Renal Cell CarcinomaFrance
-
Fox Chase Cancer CenterTerminatedMetastatic Renal Cell Carcinoma | RCCUnited States
-
Prometheus LaboratoriesCompletedMetastatic Renal Cell Carcinoma | Metastatic MelanomaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic Renal Cell Carcinoma | Advanced Solid TumorsUnited States
-
Dana-Farber Cancer InstituteBayerCompletedMetastatic Renal Cell CarcinomaUnited States
-
Leonard ApplemanPrometheus LaboratoriesCompletedMetastatic Renal Cell CarcinomaUnited States
-
PfizerCompletedRenal Cancer | Advanced or Metastatic Renal Cell CarcinomaSlovakia
-
Rennes University HospitalMinistry of Health, FranceTerminated
-
West China HospitalUnknownAdvanced Cancer | Neoadjuvant Therapy | Metastatic Kidney Cancer
-
University of MagdeburgUnknownRenal Cell Cancer | Kidney TumorGermany
-
M.D. Anderson Cancer CenterPfizerCompletedKidney Cancer | Genitourinary CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedRecurrent Renal Cell Carcinoma | Stage I Renal Cell Cancer | Stage II Renal Cell CancerUnited States
-
University of ArizonaTerminated
-
Paul MonkGenentech, Inc.TerminatedKidney CancerUnited States
-
M.D. Anderson Cancer CenterOnyx Therapeutics, Inc.Completed
-
Baylor College of MedicineCompleted
-
New Mexico Cancer Care AllianceCompleted
-
Genelux CorporationGOG FoundationRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Platinum-refractory Ovarian Cancer | Primary Peritoneal Cancer | High-grade Serous Ovarian Cancer | Endometrioid Ovarian Cancer | Ovarian Clear Cell CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingDedifferentiated Chondrosarcoma | Central Chondrosarcoma, Grade 2 | Central Chondrosarcoma, Grade 3 | Metastatic Clear Cell Sarcoma of Soft Tissue | Metastatic Primary Central Chondrosarcoma | Unresectable Primary Central ChondrosarcomaUnited States, Canada
-
AstraZenecaActive, not recruitingMelanoma | Cervical Cancer | Small Cell Lung Cancer | Triple Negative Breast Neoplasms | Advanced Solid Tumours | Non-Small-Cell Lung Cancer | Gastroesophageal Cancer | Clear Cell Renal Cell Cancer | Squamous Cell Cancer of Head and NeckUnited States, Spain, Canada, France